Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiovascular effects of cannabinoids.
Randall MD, Harris D, Kendall DA, Ralevic V. Randall MD, et al. Pharmacol Ther. 2002 Aug;95(2):191-202. doi: 10.1016/s0163-7258(02)00258-9. Pharmacol Ther. 2002. PMID: 12182966 Review.
Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation.
Wheal AJ, Cipriano M, Fowler CJ, Randall MD, O'Sullivan SE. Wheal AJ, et al. Among authors: randall md. J Pharmacol Exp Ther. 2014 Nov;351(2):457-66. doi: 10.1124/jpet.114.217125. Epub 2014 Sep 11. J Pharmacol Exp Ther. 2014. PMID: 25212218
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans.
Anderson RL, Randall MD, Chan SL. Anderson RL, et al. Among authors: randall md. Eur J Pharmacol. 2013 Apr 15;706(1-3):56-62. doi: 10.1016/j.ejphar.2013.02.034. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23499687
Vasorelaxation to capsaicin and its effects on calcium influx in arteries.
Hopps JJ, Dunn WR, Randall MD. Hopps JJ, et al. Among authors: randall md. Eur J Pharmacol. 2012 Apr 15;681(1-3):88-93. doi: 10.1016/j.ejphar.2012.02.019. Epub 2012 Feb 21. Eur J Pharmacol. 2012. PMID: 22532967
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.
Hopps JJ, Dunn WR, Randall MD. Hopps JJ, et al. Among authors: randall md. Eur J Pharmacol. 2012 Jun 5;684(1-3):102-7. doi: 10.1016/j.ejphar.2012.03.027. Epub 2012 Mar 23. Eur J Pharmacol. 2012. PMID: 22465182
Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries.
Wheal AJ, Alexander SP, Randall MD. Wheal AJ, et al. Among authors: randall md. Eur J Pharmacol. 2012 Jan 15;674(2-3):384-90. doi: 10.1016/j.ejphar.2011.11.033. Epub 2011 Nov 29. Eur J Pharmacol. 2012. PMID: 22154756
Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ, Randall MD. Wheal AJ, et al. Among authors: randall md. Eur J Pharmacol. 2009 Jan 28;603(1-3):79-85. doi: 10.1016/j.ejphar.2008.11.061. Epub 2008 Dec 9. Eur J Pharmacol. 2009. PMID: 19100733
Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol.
O'Sullivan SE, Kendall DA, Randall MD. O'Sullivan SE, et al. Among authors: randall md. J Pharmacol Exp Ther. 2006 Apr;317(1):428-38. doi: 10.1124/jpet.105.095828. Epub 2005 Dec 13. J Pharmacol Exp Ther. 2006. PMID: 16352700
Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma.
O'Sullivan SE, Tarling EJ, Bennett AJ, Kendall DA, Randall MD. O'Sullivan SE, et al. Among authors: randall md. Biochem Biophys Res Commun. 2005 Nov 25;337(3):824-31. doi: 10.1016/j.bbrc.2005.09.121. Epub 2005 Sep 29. Biochem Biophys Res Commun. 2005. PMID: 16213464
The cardiovascular actions of anandamide: more targets?
Randall MD. Randall MD. Br J Pharmacol. 2005 Jul;145(5):565-6. doi: 10.1038/sj.bjp.0706234. Br J Pharmacol. 2005. PMID: 15834438 Free PMC article. No abstract available.
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page